Satsuma Pharmaceuticals Inc (STSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2004 | 09-2004 | 06-2004 | 03-2004 | 12-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 56,305 | 40,777 | 25,467 | 11,984 | 34,913 |
| Depreciation Amortization | 14,289 | 10,611 | 7,475 | 3,080 | 12,271 |
| Income taxes - deferred | 8,760 | N/A | N/A | N/A | 6,880 |
| Other Working Capital | -29,234 | -14,767 | -7,403 | -9,005 | -9,860 |
| Loans | -4,572 | -4,572 | -3,307 | -2,461 | -3,694 |
| Other Operating Activity | 14,850 | 9,979 | 7,872 | 4,573 | 11,856 |
| Operating Cash Flow | $60,398 | $42,028 | $30,104 | $8,171 | $52,366 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -10,623 | -8,201 | -5,996 | -2,263 | -7,442 |
| Net Acquisitions | 44,031 | 44,894 | 44,894 | 44,703 | 143,631 |
| Purchase Of Investment | -1,552,019 | -1,477,206 | -939,838 | -697,224 | -1,251,424 |
| Sale Of Investment | 1,214,979 | 1,128,096 | 768,574 | 563,192 | 990,874 |
| Net Loans | -794,029 | -561,230 | -280,454 | -128,884 | -454,423 |
| Other Investing Activity | 7,169 | 5,281 | 2,047 | 382 | -6,274 |
| Investing Cash Flow | $-1,090,492 | $-868,366 | $-410,773 | $-220,094 | $-585,058 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 416,875 | 318,706 | 296,125 | 201,477 | 167,368 |
| Debt Issued | 1,401,062 | 955,582 | 518,464 | 320,000 | 635,589 |
| Debt Repayment | -1,150,896 | -748,859 | -569,823 | -334,688 | -493,526 |
| Common Stock Issued | 7,083 | 5,918 | 3,914 | 2,463 | 1,223 |
| Other Financing Activity | -36,399 | 202 | 1,405 | 1,367 | -47,103 |
| Financing Cash Flow | $1,057,802 | $865,541 | $407,784 | $239,841 | $520,308 |
| Beginning Cash Position | 65,479 | 65,479 | 65,479 | 65,479 | 77,863 |
| End Cash Position | 93,187 | 104,682 | 92,594 | 93,397 | 65,479 |
| Net Cash Flow | $27,708 | $39,203 | $27,115 | $27,918 | $-12,384 |
| Free Cash Flow | |||||
| Operating Cash Flow | 60,398 | 42,028 | 30,104 | 8,171 | 52,366 |
| Capital Expenditure | -10,623 | -8,201 | -5,996 | -2,263 | -7,442 |
| Free Cash Flow | 49,775 | 33,827 | 24,108 | 5,908 | 44,924 |